<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>101(5)</volume><submitter>Olthof EP</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>To establish the impact of the number of lymph node metastases (nLNM) and the lymph node ratio (LNR) on survival in patients with early-stage cervical cancer after surgery.&lt;h4>Material and methods&lt;/h4>In this nationwide historical cohort study, all women diagnosed between 1995 and 2020 with International Federation of Gynecology and Obstetrics (FIGO) 2009 stage IA2-IIA1 cervical cancer and nodal metastases after radical hysterectomy and pelvic lymphadenectomy from the Netherlands Cancer Registry were selected. Optimal cut-offs for prognostic stratification by nLNM and LNR were calculated to categorize patients into low-risk or high-risk groups. Kaplan-Meier overall survival analysis and flexible parametric relative survival analysis were used to determine the impact of</pubmed_abstract><journal>Acta obstetricia et gynecologica Scandinavica</journal><pagination>550-557</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9564443</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer.</pubmed_title><pmcid>PMC9564443</pmcid><pubmed_authors>Olthof EP</pubmed_authors><pubmed_authors>van der Velden J</pubmed_authors><pubmed_authors>van der Aa MA</pubmed_authors><pubmed_authors>Mom CH</pubmed_authors><pubmed_authors>Wenzel HHB</pubmed_authors><pubmed_authors>Snijders MLH</pubmed_authors></additional><is_claimable>false</is_claimable><name>The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer.</name><description>&lt;h4>Introduction&lt;/h4>To establish the impact of the number of lymph node metastases (nLNM) and the lymph node ratio (LNR) on survival in patients with early-stage cervical cancer after surgery.&lt;h4>Material and methods&lt;/h4>In this nationwide historical cohort study, all women diagnosed between 1995 and 2020 with International Federation of Gynecology and Obstetrics (FIGO) 2009 stage IA2-IIA1 cervical cancer and nodal metastases after radical hysterectomy and pelvic lymphadenectomy from the Netherlands Cancer Registry were selected. Optimal cut-offs for prognostic stratification by nLNM and LNR were calculated to categorize patients into low-risk or high-risk groups. Kaplan-Meier overall survival analysis and flexible parametric relative survival analysis were used to determine the impact of</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-05T11:49:07.946Z</modification><creation>2025-04-05T11:49:07.946Z</creation></dates><accession>S-EPMC9564443</accession><cross_references><pubmed>35218205</pubmed><doi>10.1111/aogs.14316</doi></cross_references></HashMap>